Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$0.63 - $4.87
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Latest price
Market Cap | $1.77B |
EV | $1.57B |
Shares Outstanding | 515.86M |
Beta | 1.99 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $4.75 |
P/E 2025E | - |
P/Revenue 2025E | 0.95x |
Revenue | -2.30% |
EPS | 60.10% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 22.10% |
EPS | 12.60% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 22.51% |
Net Profit Margin 2025E | -4.77% |
ROE 2025E | -15.05% |
ROCE 2024 | -14.75% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Clover Health Investments, Corp.
CLOV
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Toy, Andrew
Employees
570
Website
www.cloverhealth.com/en/IPO Date
2020-06-12
Headquarters
3401 Mallory Lane, Suite 210, Franklin, Tennessee, 37067, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved